uniQure N.V. Weighted Average Number of Shares Outstanding, Basic and Diluted
uniQure N.V. (QURE) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 45.47 million shares for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2021-05-10
- uniQure N.V. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 45.47M shares, a 2.69% increase year-over-year.
- uniQure N.V. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-12-31 was 44.73M shares, a 2.29% increase year-over-year.
- uniQure N.V. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-09-30 was 44.47M shares, a 9.16% increase year-over-year.
- uniQure N.V. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-06-30 was 44.39M shares, a 17.35% increase year-over-year.
- uniQure N.V. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 44.47M shares, a 11.17% increase from fiscal 2019.
- uniQure N.V. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 40.00M shares, a 12.23% increase from fiscal 2018.
- uniQure N.V. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 35.64M shares, a 32.08% increase from fiscal 2017.
- uniQure N.V. weighted average number of shares outstanding, basic and diluted for fiscal 2017 was 26.98M shares, a 7.78% increase from fiscal 2016.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-03-31 | 45.47M shares 10-Q · filed 2021-05-10 | 45.10M shares derived: average of 2 quarters · filed 2021-05-10 | 44.89M shares derived: average of 3 quarters · filed 2021-05-10 | 44.76M shares derived: average of 4 quarters · filed 2021-05-10 |
| 2020-12-31 | 44.73M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | 44.60M shares derived: average of 2 quarters · filed 2021-03-01 | 44.53M shares derived: average of 3 quarters · filed 2021-03-01 | 44.47M shares 10-K · filed 2021-03-01 |
| 2020-09-30 | 44.47M shares 10-Q · filed 2020-10-27 | 44.43M shares derived: average of 2 quarters · filed 2020-10-27 | 44.38M shares 10-Q · filed 2020-10-27 | 44.22M shares derived: average of 4 quarters · filed 2021-05-10 |
| 2020-06-30 | 44.39M shares 10-Q · filed 2020-07-30 | 44.33M shares 10-Q · filed 2020-07-30 | 44.13M shares derived: average of 3 quarters · filed 2021-05-10 | 43.28M shares derived: average of 4 quarters · filed 2021-05-10 |
| 2020-03-31 | 44.28M shares 10-Q · filed 2021-05-10 | 44.00M shares derived: average of 2 quarters · filed 2021-05-10 | 42.91M shares derived: average of 3 quarters · filed 2021-05-10 | 41.64M shares derived: average of 4 quarters · filed 2021-05-10 |
| 2019-12-31 | 43.72M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | 42.23M shares derived: average of 2 quarters · filed 2021-03-01 | 40.76M shares derived: average of 3 quarters · filed 2021-03-01 | 40.00M shares 10-K · filed 2021-03-01 |
| 2019-09-30 | 40.74M shares 10-Q · filed 2020-10-27 | 39.28M shares derived: average of 2 quarters · filed 2020-10-27 | 38.76M shares 10-Q · filed 2020-10-27 | 38.39M shares derived: average of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | 37.82M shares 10-Q · filed 2020-07-30 | 37.75M shares 10-Q · filed 2020-07-30 | 37.61M shares derived: average of 3 quarters · filed 2021-03-01 | 37.52M shares derived: average of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | 37.68M shares 10-Q · filed 2020-04-29 | 37.51M shares derived: average of 2 quarters · filed 2021-03-01 | 37.42M shares derived: average of 3 quarters · filed 2021-03-01 | 37.12M shares derived: average of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | 37.34M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | 37.29M shares derived: average of 2 quarters · filed 2021-03-01 | 36.93M shares derived: average of 3 quarters · filed 2021-03-01 | 35.64M shares 10-K · filed 2021-03-01 |
| 2018-09-30 | 37.25M shares 10-Q · filed 2019-10-28 | 36.73M shares derived: average of 2 quarters · filed 2019-10-28 | 35.07M shares 10-Q · filed 2019-10-28 | 34.12M shares derived: average of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | 36.21M shares 10-Q · filed 2019-07-29 | 33.97M shares 10-Q · filed 2019-07-29 | 33.07M shares derived: average of 3 quarters · filed 2020-03-02 | 31.21M shares derived: average of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | 31.71M shares 10-Q · filed 2019-04-29 | 31.50M shares derived: average of 2 quarters · filed 2020-03-02 | 29.55M shares derived: average of 3 quarters · filed 2020-03-02 | 28.55M shares derived: average of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | 31.30M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | 28.47M shares derived: average of 2 quarters · filed 2020-03-02 | 27.50M shares derived: average of 3 quarters · filed 2020-03-02 | 26.98M shares 10-K · filed 2020-03-02 |
| 2017-09-30 | 25.63M shares 10-Q · filed 2018-11-06 | 25.60M shares derived: average of 2 quarters · filed 2018-11-06 | 25.55M shares 10-Q · filed 2018-11-06 | 25.47M shares derived: average of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | 25.56M shares 10-Q · filed 2018-08-08 | 25.50M shares 10-Q · filed 2018-08-08 | 25.41M shares derived: average of 3 quarters · filed 2019-02-28 | 25.34M shares derived: average of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | 25.44M shares 10-Q · filed 2018-04-30 | 25.34M shares derived: average of 2 quarters · filed 2019-02-28 | 25.27M shares derived: average of 3 quarters · filed 2019-02-28 | 25.22M shares derived: average of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | 25.23M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | 25.19M shares derived: average of 2 quarters · filed 2019-02-28 | 25.15M shares derived: average of 3 quarters · filed 2019-02-28 | 25.04M shares 10-K · filed 2019-02-28 |
| 2016-09-30 | 25.14M shares 10-Q · filed 2017-11-01 | 25.11M shares derived: average of 2 quarters · filed 2017-11-01 | 24.97M shares 10-Q · filed 2017-11-01 | |
| 2016-06-30 | 25.08M shares 10-Q · filed 2017-08-08 | 24.89M shares 10-Q · filed 2017-08-08 | ||
| 2016-03-31 | 24.70M shares 10-Q · filed 2017-05-09 | |||
| 2015-12-31 | 22.08M shares 10-K · filed 2018-03-14 | |||
| 2014-12-31 | 17.12M shares 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |